Xigris (Zy-gris, drotrecogin alfa), the first drug APPROVED for treating severe sepsis

March 2003

Lilly is now marketing Xigris (Zy-gris, drotrecogin alfa), the first drug APPROVED for treating severe sepsis.

Until now, the main treatment for severe sepsis was antibiotics.

Xigris is the first drug shown to improve survival in cases of severe septic infections.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

C-reactive protein (CRP)" will soon become common vocabulary
Some patients with peanut allergy are still being prescribed Atrovent or Combivent inhalers
Heart Failure but now many patients are getting spironolactone inappropriately
Cholesterol Is raising the statin dose better than adding a second drug?
Cholesterol Crestor by AstraZeneca is hitting the shelves
Infectious Diseases Xigris (Zy-gris, drotrecogin alfa), the first drug APPROVED for treating severe sepsis
Cardiology LOW-INTENSITY warfarin to prevent recurrent venous thromboembolism
Cardiology ibuprofen reduces the effectiveness of ASA
SSRIs can lead to increased GI bleeding
acetaminophen is often NOT enough for osteoarthritis patients
Diabetes COMPREHENSIVE treatment of type 2 diabetes cuts in HALF the risk of heart disease
Women's Health Avlimil, a new herbal supplement for female sexual dysfunction
Women's Health treating hair loss in women
Natural Medicines How important is it to stop herbs and other supplements before surgery?